Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|December 18, 2015
Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and reviewJonathan D Schoenfeld, Anand Mahadevan, Scott R Floyd, et al.JAMA Network Open|April 26, 2023
Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain MetastasesDavid J Carpenter, Jim Leng, Muzamil Arshad, et al.International Journal of Radiation Oncology, Biology, Physics|October 26, 2022
A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain MetastasesAndrew T Fairchild, Joseph K Salama, Walter F Wiggins, et al.Frontiers in Oncology|June 7, 2022
Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic RadiosurgeryChristine Park, Evan D Buckley, Amanda E D Van Swearingen, et al.Journal of Neuro-Oncology|September 1, 2011
Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimenChe-Chuan Wang, Scott R Floyd, Chin-Hong Chang, et al.Neuro-Oncology Practice|June 9, 2025
Seizure risk factors and management approaches in patients with brain metastasesEugene J Vaios, Spencer Maingi, Kristen Batich, et al.Journal of Neuro-Oncology|February 10, 2024
Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgeryAndrew Fairchild, Joseph K Salama, Devon Godfrey, et al.Advances in Radiation Oncology|November 9, 2017
The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicityRachel B Jimenez, Brian M Alexander, Anand Mahadevan, et al.Neuro-Oncology Advances|September 14, 2023
Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphomaBronwen E Foreman, Trey C Mullikin, Scott R Floyd, et al.Frontiers in Molecular Biosciences|April 24, 2023
MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approachJustine R Stehn, Scott R Floyd, Erik W Wilker, et al.Pageof 7